N.W. Fulcher Limited Acquires Convertible Debentures of Nova Leap Health Corp.

HALIFAX, Nova Scotia, Dec. 31, 2019 (GLOBE NEWSWIRE) — N.W. Fulcher Limited (“Fulcher”) announces that it has acquired ownership of unsecured convertible debentures in the aggregate principal amount of $1,000,000 (the “Debentures”) of Nova Leap Health Corp. (TSXV: NLH) (“Nova Leap”), with its head office at 5003-7071 Bayers Road, Halifax, Nova Scotia, B3L 2C2. Fulcher is owned and controlled by Wayne Fulcher. The Debentures are convertible into common shares of Nova Leap at a conversion price of $0.52 per common share at any time until the date that is five (5) years after the issue date. The Debentures bear interest at the rate of 8.0% per annum, payable semi-annually.
The Debentures were purchased by way of a private placement and were acquired for investment purposes. Fulcher may, from time to time, increase or decrease its holdings of securities of Nova Leap, depending on market and other conditions.Fulcher’s acquisition of the Debentures, assuming exercise of the 1,025,000 warrants to acquire common shares held by Fulcher (the “Warrants”) and conversion of the Debentures into common shares of Nova Leap, represents approximately 2.98% of the common shares of Nova Leap issued and outstanding.Immediately before the acquisition, Fulcher and its joint actors owned 9,508,333 common shares of Nova Leap and the Warrants. Assuming conversion of the Warrants, the aggregate number of common shares of Nova Leap held by Fulcher and its joint actors before the acquisition represented approximately 16.80% of all issued and outstanding common shares of Nova Leap.Following the acquisition and assuming exercise of the Warrants and conversion of the Debentures, Fulcher and its joint actors now own 12,456,409 common shares of Nova Leap, which represents approximately 19.28% of all issued and outstanding common shares of Nova Leap.Further details on the information above concerning Fulcher may be obtained from the Early Warning Report filed on SEDAR or by contacting Christopher Dobbin, President & CEO of Nova Leap Health Corp. at 902.401.9480.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.